Intuitive Surgical, Inc. (NASDAQ:ISRG) more or less invented modern robotic surgery with its da Vinci system, and for two ...

Intuitive Surgical's da Vinci surgical robot is an industry leader in one specific area. Medtronic offers both a surgical robot and a more diverse business beyond it. Moreover, Medtronic is working to ...

Intuitive obtained FDA clearance for cardiovascular procedures in January. Outside of a renewed push into cardiovascular ...

Intuitive Surgical is rated HOLD at $406.63, with a probability-weighted fair value of ~$430/share and 82% confidence in the ...

Intuitive Surgical (ISRG) stock's Q2 2026: revenue +19% to $2.89B, procedures +15%. ISRG’s 37.72x FY1 forward P/E warrants a ...

Intuitive Surgical (NASDAQ:ISRG) enters October on fresh robotic surgery approvals as healthcare leads the sector rotation.

Tesla Inc’s TSLA Optimus is built around the biggest ambition in robotics: a general-purpose humanoid that can handle a wide ...

Intuitive Surgical stock remains a key name in the fast?growing robotic surgery market, and the company’s latest quarterly ...

Intuitive Surgical has delivered a 43.1% gain over the past three years, even as the stock has been weaker more recently.

Intuitive Surgical’s da Vinci platform has turned robotic surgery from moonshot to default option. Now, the company is racing rivals with new systems, instruments, and data-driven tools. For years, ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

There is absolutely nothing wrong with Intuitive Surgical's business. In fact, the da Vinci surgical robot is industry-leading technology. And it is still selling well, with 427 new systems put in ...